Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma
David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mark Bower(Chelsea and Westminster Hospital), Emanuela Messina(Vita-Salute San Raffaele University), Hamid Hasson(Vita-Salute San Raffaele University), Marco Merli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Nicole Pagani(Chelsea and Westminster Hospital), Alessia Dalla Pria(Hammersmith Hospital), Shiraz Jamshaid(Hammersmith Hospital), Kizzy Parker(Chelsea and Westminster Hospital), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Mark Nelson(University of Tasmania), Rohini Sharma(Hammersmith Hospital)
Cited by 13
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653